Stockreport

Day One targets the growing ADC market with MabCare acquisition [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF The Brisbane, California-based biotech company is paying out $55m upfront for the novel ADC targeting protein-tyrosine kinase 7 (PTK7). Under the terms of the agreement [Read more]